Polypharmacy, chronic kidney disease, and incident fragility fracture: a prospective cohort study
ConclusionHyperpolypharmacy is associated with an increased risk of fragility fracture regardless of CKD status, and has a strong impact on incident fragility fractures in dialysis-dependent CKD patients.
Source: Journal of Bone and Mineral Metabolism - Category: Orthopaedics Source Type: research
More News: Chronic Kidney Disease | Dialysis | Orthopaedics | Osteoporosis | Study | Urology & Nephrology